Sub-Toxic Dose of Apigenin Sensitizes HepG2 Cells to TRAIL through ERK-Dependent Up-Regulation of TRAIL Receptor DR5

다국어 초록 (Multilingual Abstract)

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is regarded as a promising candidate for anti-cancer therapy due to its selective toxicity to cancer cells. Nevertheless, because of TRAIL resistance in some cancer cells, combined treatment with sensitizing agents is required to enhance the anticancer potential of TRAIL. In this study, we investigated the underlying mechanism of apigenin-induced sensitization of HepG2 cells to TRAIL-in-duced cell death. Synergistic induction of apoptosis by combination was confirmed by examining the typical morphology changes of apoptosis, PARP-cleavage, and activation of effector caspases. Z-VAD-fmk, a pan-caspase inhibitor, inhibited the enhanced cell death by combined treatment of apigenin and TRAIL, demonstrating that a caspase-dependent pathway is involved in apigenin/TRAIL- mediated apoptosis. In addition, we found that apigenin/ TRAIL co-treatment up-regulates DR5 cell surface expression. The synergistic induction of cell death by the apigenin/TRAIL combination was significantly attenuated by DR5 blocking chimera antibody. Next, using pharmacological inhibitors, we found that ERK activation is involved in the induction of DR5 expression. Inhibition of ERK1/2 by U0126 significantly decreased the apigenin/TRAIL-induced DR5 expression and apoptosis. Taken together, our results indicate that apigenin can enhance the apoptotic effect of TRAIL via ERK-induced up-regulation of DR5.

참고문헌 (Reference)

1 Yodkeeree, S, "Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: evidence for an essential role of reactive oxygen species" 69 : 6581-6589, 2009

2 Kasibhatla, S, "Why target apoptosis in cancer treatment" 2 : 573-580, 2003

3 Prasad, S, "Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK" 286 : 5546-5557, 2011

4 van Noesel, M.M, "Tumor-specific down-regulation of the tumor necrosis factorrelated apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation" 62 : 2157-2161, 2002

5 Drosopoulos, K.G, "Transformation by oncogenic RAS sensitizes human colon cells to TRAILinduced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway" 280 : 22856-22867, 2005

6 Rupnow, B.A, "The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy" 4 : 115-143, 1999

7 Pan, G, "The receptor for the cytotoxic ligand TRAIL" 276 : 111-113, 1997

8 Degli-Esposti, M.A, "The novel receptor TRAILR4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain" 7 : 813-820, 1997

9 Häcker, G, "The morphology of apoptosis" 301 : 5-17, 2000

10 Horinaka, M, "The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosisinducing ligand" 5 : 945-951, 2006

11 Walczak, H, "The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems" 256 : 58-66, 2000

12 Ashkenazi, A, "Targeting death and decoy receptors of the tumour-necrosis factor superfamily" 2 : 420-430, 2002

13 Walczak, H, "TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL" 16 : 5386-5397, 1997

14 Dai-Wu Seol, "TRAIL, a Mighty Apoptosis Inducer" 한국분자세포생물학회 15 (15): 283-293, 2003

15 Malhi, H, "TRAIL resistance results in cancer progression: a TRAIL to perdition" 25 : 7333-7335, 2006

16 Mahalingam, D, "TRAIL receptor signalling and modulation: Are we on the right TRAIL" 35 : 280-288, 2009

17 Kruyt, F.A.E, "TRAIL and cancer therapy" 263 : 14-25, 2008

18 Xu, Y, "Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells" 6 : e29169-, 2011

19 Lu, G, "Synergistic effect of celecoxib on TRAIL-induced apoptosis in hepatocellular carcinoma cells" 28 : 629-634, 2010

20 Gupta, S, "Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells" 287 : 914-920, 2001

21 Simon, H.U, "Role of reactive oxygen species (ROS) in apoptosis induction" 5 : 415-418, 2000

22 Jalving, M, "Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer" 21 : 321-339, 2005

23 Kang, C.H, "Piceatannol enhances TRAIL-induced apoptosis in human leukemia THP-1 cells through Sp1- and ERK-dependent DR5 up-regulation" 25 : 605-612, 2011

24 Gupta, S.C, "Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species-and ERK-dependent up-regulation of death receptors, p53, and Bax" 286 : 1134-1146, 2011

25 Shukla, S, "Molecular targets for apigenininduced cell cycle arrest and apoptosis in prostate cancer cell xenograft" 5 : 843-852, 2006

26 Wada, T, "Mitogen-activated protein kinases in apoptosis regulation" 23 : 2838-2849, 2004

27 Zhang, L, "Mechanisms of resistance to TRAILinduced apoptosis in cancer" 12 : 228-237, 2004

28 Soo Im Choi, "Mechanism of Apoptosis Induced by Apigenin in HepG2 Human Hepatoma Cells: Involvement of Reactive Oxygen Species Generated by NADPH Oxidase" 대한약학회 30 (30): 1328-1335, 2007

29 Czeczot, H, "Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs" 240 : 209-216, 1990

30 Shigeno, M, "Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NFkappa B inactivation" 22 : 1653-1662, 2003

31 Sung, B, "Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL" 285 : 35418-35427, 2010

32 Cuzick, J, "Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy" 12 : 447-453, 1994

33 Cohen, G.M, "Caspases: the executioners of apoptosis" 326 : 1-16, 1997

34 Yang, Y, "Caspase-dependent apoptosis and -independent poly(ADP-ribose) polymerase cleavage induced by transforming growth factor beta1" 36 : 223-234, 2004

35 Kumar, S, "Caspase function in programmed cell death" 14 : 32-43, 2007

36 Fan, T.-J, "Caspase family proteases and apoptosis" 37 : 719-727, 2005

37 Redding, S.W, "Cancer therapy-related oral mucositis" 69 : 919-929, 2005

38 Moon, D.O, "Butein sensitizes human hepatoma cells to TRAIL-induced apoptosis via extracellular signal-regulated kinase/Sp1-dependent DR5 upregulation and NF-kappaB inactivation" 9 : 1583-1595, 2010

39 Russo, A, "Apoptosis: a relevant tool for anticancer therapy" 17 (17): 115-123, 2006

40 Xu, L., "Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NFkappaB activation pathway" 121 : 74-83, 2008

41 He, S, "Antitumor effects of soluble TRAIL in human hepatocellular carcinoma" 25 : 51-54, 2005

42 Nakshatri, H, "Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase" 23 : 7330-7344, 2004

43 van Engeland, M, "Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure" 31 : 1-9, 1998

44 Pan, G, "An antagonist decoy receptor and a death domain-containing receptor for TRAIL" 277 : 815-818, 1997

45 Chen, C.Y, "6-dehydrogingerdione sensitizes human hepatoblastoma Hep G2 cells to TRAIL-induced apoptosis via reactive oxygen species-mediated increase of DR5" 58 : 5604-5611, 2010